Navigation Links
Atrazine is the main weapon against weeds in sweet corn, with few alternatives
Date:5/19/2010

Life without atrazine would complicate weed management in corn, especially for sweet corn growers. A study at the University of Illinois looked at 175 sweet corn fields in the Midwest to find out just how important this 50-year-old, broad-spectrum herbicide is in sweet corn grown for processing.

"If the use of atrazine was phased out completely, our data indicate the greatest burden would be on those growers who rely on less tillage for weed control, have particularly weedy fields, have early season crop production, and grow sweet corn in rotation with other vegetables such as snap or lima beans," said U of I and USDA Agricultural Research Service ecologist Marty Williams. "Vegetable crops have fewer herbicide options and there tends to be poorer levels of weed control in those crops. When more weeds escape, more weed seed are produced, and crops succeeding those vegetables can have challenging weed problems."

The U.S. Environmental Protection Agency completed re-registration of atrazine in 2006, but due to controversy over human health and environmental safety concerns, launched a special review and re-evaluation of atrazine last November.

Registered use rates have been in decline for several decades, and atrazine use is increasingly being scrutinized at state and federal levels. Atrazine use in field corn dominates the debate; sweet corn represents only about 1 percent of total corn acres being treated with atrazine. But because atrazine may be far more important in sweet corn production, Williams wanted to assess how atrazine is currently being used by sweet corn growers, and how an EPA ban on atrazine might affect them.

"Atrazine is the single most widely used herbicide in sweet corn, applied to fields before crop emergence, after crop emergence, or at both times," Williams said. "Manufacturers of many of the other herbicides recommend tank-mixing with atrazine to increase their products' effectiveness."

'/>"/>
Contact: Debra Levey Larson
dlarson@illinois.edu
217-244-2880
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Pesticide atrazine can turn male frogs into females
2. Multifunctional polymer neutralizes both biological and chemical weapons
3. UCF professors vaccine could be lethal weapon against malaria, cholera
4. Lombardi research: Monoclonal antibodies primed to become potent immune weapons against cancer
5. Researchers identify potential new weapon in battle against HIV infection
6. Control of blood vessels a possible weapon against obesity
7. A new weapon in the fight against obesity and diabetes
8. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
9. Researcher working on destruction of chemical weapons
10. Francisella tularensis: Stopping a biological weapon
11. UD plant biologists uncover top wetland plants hidden weapon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2015)... August 12, 2015 As the ... payment innovation and advanced biometrics technology is accelerating beyond ... consumers rely on using their credit cards, the digital ... future for payment services led by companies in the ... :  Google, Inc. (NASDAQ: GOOG ), Apple Inc. ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2
... BUFFALO, NY -- Exposure to air pollution early in ... child may alter her DNA and may be associated with ... at Buffalo have shown. The findings indicated that higher ... may increase levels of E-cadherin, a protein important to the ...
... won $100 and then offered you a few dollars, would ... be, sure, why not? "But human decision making does not ... Virginia Tech and director of the Human Neuroimaging Laboratory at ... research conducted over the last three decades; only about one-fourth ...
... of the Deepwater Horizon oil spill that took the lives ... of coastal Louisiana, it,s difficult to put the complicated relationship ... have thus far not been as pervasive as originally feared, ... too early to tell. However, dependence upon oil has not ...
Cached Biology News:Air pollution exposure affects chances of developing premenopausal breast cancer 2Functional MRI shows how mindfulness meditation changes decision-making process 2Functional MRI shows how mindfulness meditation changes decision-making process 3Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 2Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 3Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 4Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 5
(Date:8/26/2015)... 26, 2015  The Diabetes Research Institute (DRI), ... Miami Miller School of Medicine, announced today that ... test for the first time a novel transplant ... FDA approved Phase I/II study builds upon decades ... an important first step toward the development of ...
(Date:8/26/2015)... Intrexon Corporation (NYSE: XON ), a ... its previously announced public offering of common stock, including ... option to purchase an additional 731,707 shares of common ... share.  The exercise of the underwriters, option brought the ... Intrexon to 5,609,756 shares and increased the total gross ...
(Date:8/26/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has been informed that Magnum ... owned by Mr. Yuen Kam, chairman of the board ... shares (the "Shares") of  Excellent China Healthcare Investment Limited ...
(Date:8/26/2015)... CORAL SPRINGS, Florida , August 26, 2015 ... one of the biggest factors fueling the optimism ... FDA approvals, M&A,s, collaborations and life sciences advancements.  ... and developments are Pressure BioSciences, Inc. (OTCQB: PBIO), ... Inc. (NASDAQ: SRPT ), Raptor Pharmaceutical Corp. ...
Breaking Biology Technology:Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... 29, 2011 USChina Channel LLC announced today: ... Inc. ("CBI") filed Form 8-k of SEC, to announce the ... process is going very well. We already have ... the vote. Followings are the interim vote results for the ...
... Morphotek®, Inc., a subsidiary of Eisai Inc., ... collaboration and license agreement with Biocare Medical, LLC. ... develop and commercialize an immunohistochemical (IHC) diagnostic kit ... human folate receptor alpha (FRA) with Biocare,s intelliPATH™ ...
... NEW YORK, March 29, 2011 Reportlinker.com ... is available in its catalogue: ... and Europe - Development and Approval of ... http://www.reportlinker.com/p0464103/Biosimilars-Approval-Pathways-in-the-US-and-Europe---Development-and-Approval-of-Biosimilar-mABs-May-Face-Tough-Regulatory-Environment.html ...
Cached Biology Technology:Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information 2Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information 3Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues 2Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues 3Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 2Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 3Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 4Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 5Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 6Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 7Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 8Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 9Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 10Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 11Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 12Reportlinker Adds Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment 13
... Features, Special optically clear polystyrene formulation ... in immunoassay applications , Plates are ... coefficients of variation , Eight-well strips ... strip loss while in use even if ...
...
... Pierce scientists developed the Easy-Titer Human IgM ... a simple, sensitive, and easy-to-perform assay for ... an ELISA. This kit incorporates a simple ... of IgM concentration from 15-500 ng/ml in ...
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
Biology Products: